Zusammenfassung
Gastrointestinale Stromatumoren (GIST) sind die häufigsten mesenchymalen Tumoren des Gastrointestinaltraktes. Entscheidendes diagnostisches Kriterium ist der Nachweis einer KIT-Expression (CD117). Trotz aller Fortschritte in der medikamentösen Therapie stellt die komplette chirurgische Resektion (R0) nach wie vor die Standardbehandlung resektabler GIST dar und ist Voraussetzung für einen kurativen Therapieansatz. Die Datenlage zum Stellenwert laparoskopischer Resektionsverfahren ist derzeit noch unzureichend. Unter dem Aspekt der minimalen Invasivität können insbesondere kleine GIST des Magens eine geeignete Indikation für ein chirurgisch-laparoskopisches Vorgehen darstellen. Grundsätzlich sollten laparoskopische GIST-Resektionen aber nur von interdisziplinären Teams aus laparoskopisch, endoskopisch und onkologisch gleichermaßen erfahrenen Chirurgen und Gastroenterologen vorgenommen werden.
Abstract
Gastrointestinal stromal tumors (GIST) are the most frequent soft tissue tumors of the gastrointestinal tract. The demonstration of KIT expression (CD117) defined GIST as a distinct tumor entity. Despite many improvements in the medical therapy, complete tumor resection remains the standard treatment for resectable GIST and is the precondition for cure. Data concerning the role of laparoscopic surgery are sparse, but small gastric GIST (<5 cm) could be a good indication for laparoscopic procedures. In principle laparoscopic GIST resections should be performed only by interdisciplinary teams of surgeons and gastroenterologists experienced in laparoscopy, endoscopy, and oncology.
Literatur
Blay J-Y, Bonvalot S, Casali P et al. (2005) Consensus meeting for the managment of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20–21 March 2004, under the Auspices of ESMO. Ann Oncol 16: 566–578
Basse L, Jakobsen DH, Bardram L et al. (2005) Functional recovery after open versus laparoscopic colonic resection. A randomized, blinded study. Ann Surg 241: 416–423
Bümming P, Andersson J, Meis-Kindblom JM et al. (2003) Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer 89: 460–464
Cameron S, Haller F, Dudas J et al. (2008) Immune cells in primary gastrointestinal stromal tumors. Eur J Gastroenterol Hepatol 20: 327–334
Catena F, Di Battista M, Fusaroli P et al. (2008) Laparoskopic treatment of gastric GIST: report of 21 cases and literature’s review. J Gastrointest Surg 12: 561–568
Corless CL, McGreevey L, Haley A et al. (2002) KIT mutations are common in incidental gastrointestinal stromal tumors one centimetre or less in size. Am J Pathol 160: 1567–1572
DeMatteo RP, Lewis JJ, Leung D et al. (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231: 51–58
DeMatteo RP, Heinrich MC, El-Rifai WM, Demetri G (2002) Clinical management of gastrointestinal stromal tumors: before and after STI571. Hum Pathol 33: 466–477
Demetri GD, Blanke D (2004) NCCN Task Force Report. Optimal management of patients with gastrointestinal stromal tumors (GIST): expansion and update of NCCN Clinical Guidelines. J Natl Comp Cancer Network [Suppl 1] 2: 1–26
Emory TS, Sobin LH, Lukes L et al. (1999) Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 23: 82–87
Fletcher C, Berman JJ, Corless C et al. (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33: 459–465
Fong Y, Coit DG, Woodruff JM, Brennan MF (1993) Lymph node metastasis from soft tissue sarcoma in adults. Ann Surg 217: 72–77
Gunawan B, Bergmann F, Höer J et al. (2002) Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. Hum Pathol 33: 316–321
Haller F, Happel N, Schulten HJ et al. (2007) Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors. Mod Pathol 20: 1103–1111
Haller F, Schulten HJ, Armbrust T et al. (2007) Multicentric Sporadic Gastrointestinal Stromal Tumors (GISTs) of the Stomach With Distinct Clonal Origin: Differential Diagnosis to Familial and Syndromal GIST. Variants and Peritoneal Metastasis. Am J Surg Pathol 31: 933–937
Heinrich MC, Rubin BP, Longley BJ, Fletcher JA (2002) Biology and genetic aspects of gastrointestinal stromal tumors: kit activation and cytogenetic alterations. Hum Pathol 33: 484–495
Hiki N, Yamamoto Y, Fukunaga T et al. (2007) Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc
Hindmarsh A, Koo B, Lewis M, Rhodes M (2005) Laparoscopic resection of gastric stromal tumors. Surg Endosc 19: 1109–1112
Hirota S, Isozaki K, Moriyama Y et al. (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279: 577–580
Hohenberger P (2003) Neue Konzepte der chirurgischen Therapie gastrointestinaler Stromatumore (GIST). Viszeralchirurgie 38: 379–386
Joensuu H, Roberts PJ, Sarlomo-Rikala M et al. (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344: 1052–1056
Kindblom LG, Meis-Kindblom, Bümming P et al. (2002) Incidence, prevalence, phenotype and biologic spectrum of gastrointestinal stromal cell tumors (GIST) – a population-based study of 600 cases. Ann Oncol [Suppl 5] 13: 157
Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM (1998) Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152: 1259–1269
Langer C, Gunawan B, Schüler P et al. (2003) Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 90: 332–339
Langer C, Schüler P, Gunawan B et al. (2003) Gastrointestinale Stromatumore (GIST) aus chirurgischer Sicht. Viszeralchirurgie 38: 374–378
Ludwig K, Weiner R, Bernhardt J (2003) Minimal-invasive Resektionen von Magentumoren. Chirurg 74: 632–637
Matthews BD, Walsh RM, Kercher KW et al. (2002) Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc 16: 803–807
Miettinen M, El-Rifai W, Sobin LH, Lasota J (2002) Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol 33: 478–483
Nguyen SQ, Divino CM, Wang JL, Dikman SH (2006) Laparoscopic management of gastrointestinal stromal tumors. Surg Endosc 20: 713–716
Novitsky Y, Kercher K, Sing R, Heniford B (2006) Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 243: 738–747
Reichardt P, Pink D, Hohenberger P (2002) Paradigmawechsel in der Therapie gastrointestinaler Stromatumoren. Onkologe 8: 378–383
Reichardt P, Pink D, Mrozek A et al. (2004) Gastrointestinale Stromatumoren (GIST). Z Gastroenterol 42: 327–331
Sarkomo-Rikala M, Kovatich AJ, Barusevisius A, Miettinen M (1998) CD117. A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11: 728–734
Schindler CG, Armbrust T, Gunawan B et al. (2005) Gastrointestinal Stromal Tumor (GIST) – Single Center Experience of prolonged treatment with Imatinib. Z Gastroenterol 43: 267–723
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Langer, C., Schüler, P., Becker, H. et al. Gastrointestinale Stromatumoren aus chirurgischer Sicht. Chirurg 79, 644–649 (2008). https://doi.org/10.1007/s00104-008-1528-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-008-1528-4